Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to presentation of BioArctic’s Interim Report for the first quarter of 2019 on May 9, at 9.30 a.m. CET

Stockholm, Sweden, April 29, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) to publish the company’s Interim Report for the period January – March 2019 on Thursday,May 9, 2019 at 08:00 a.m. CET. BioArctic invites to an audiocast with teleconference (in English) for investors, analysts and media on May 9, at 09:30 – 10:30 a.m. CET. Gunilla Osswald, CEO, and Jan Mattsson, CFO, to present BioArctic and comment on the Interim Report for the first quarter of 2019 followed by a Q&A-session. Sweden: + 46 8 505 583 53Denmark: + 45 781 501 07Germany: + 49 692 222 203 80The

Lynparza receives positive EU CHMP opinion for 1st

29 April 2019 07:00 BST Lynparza receives positive EU CHMP opinion for 1st-linemaintenance treatment of BRCA-mutated advanced ovarian cancer AstraZeneca and MSD's Lynparza is the only PARP inhibitor to demonstratean improvement in progression-free survival for patients in this setting AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion, recommending Lynparza(olaparib) as a 1st-line

Nitro Games Oyj: Interim Report Jan – Mar 2019

Reporting period January – March 2019 · Revenues (Jan - Mar): 25,2 KEUR (571,0 KEUR on corresponding period 2018). · EBITDA: – 1 315,5 KEUR (- 953,6 KEUR). · EBIT: –1 472,1 KEUR (-1 110,3 KEUR). · Net profit: –1 474,9 KEUR (-1 114,7 KEUR). · Cash and cash equivalents: 2 029,8 KEUR (31 March 2019). · Short-term receivables: 168,6 KEUR (31 March 2019). Significant events during January – March 2019 · Started cooperation negotiations: streamlining organization and teams, executing cost savings. · New roadmap for Heroes of Warland: First updates were released

Victoria Park signs agreement for the construction of 16 new flats in Borås

Victoria Park has signed an agreement concerning the construction of 16 new flats in the Hässleholmen district of Borås. The project involves the densification of an existing property and will comprise rental units, with occupancy scheduled to begin in April 2020. Since 2016, Victoria Park has owned a property at the address Solvarvsgatan in Hässleholmen, that current houses 350 flats. The property includes a building right for a site previously occupied by an older building. Victoria Park is now utilising this building right as a means of densifying the area with an additional 16 rental

Wihlborgs letting an additional 1,700 m² for police training at Malmö University

Last summer, Malmö University signed an agreement with Wihlborgs for 9,000 m² for police training in Malmö. Now the university has signed a ten-year agreement for an additional 1,700 m², primarily lecture halls.Police training at Malmö University started in January, and in August the training is moving to Kranen 2 in Dockan. Wihlborgs is currently conducting a substantial redevelopment of this property to meet the need for space for research facilities, firearms ranges, training environments and a garage for police vehicles, among others. These premises will enter operation in July 2019 and

Hansa Biopharma Interim Report January–March 2019

MAA filing of IDEFIRIX (imlifidase) in Europe marks a milestone in Hansa’s evolution into a commercial stage biopharmaceutical companyJanuary – March 2019 Highlights · The European Medicines Agency (EMA) accepted Hansa’s Marketing Authorization Application (MAA) for review of IDEFIRIX (imlifidase). This acceptance marks the beginning of the regulatory review process for IDEFIRIX in the European Union (EU). IDEFIRIX has both EU Orphan Drug Designation and PRIority MEdicine (PRIME) designation. An opinion of the EMA Committee for Medicinal Products for Human Use (CHMP) is expected within

Nordic Nanovector appoints Fredrik Haavind as Head of Legal and Compliance

Oslo, Norway, 29 April 2019 Nordic Nanovector ASA (OSE: NANO) announces the appointment of Fredrik Haavind as the newly established Head of Legal and Compliance. Mr Haavind has 16 years of broad legal and compliance experience in Norwegian and International businesses, including international contracts law, governance and compliance, M&A, corporate and securities laws and regulations, with experience from in-house legal departments, law firms and the courts. He joins Nordic Nanovector from Fugro N.V., a global provider of geo-intelligence listed on Euronext, Amsterdam, where he acted as

Q1 2019: Revenue growth and strong cash flow starts the year

Significant events in the first quarter · First-quarter net sales rose to MSEK 138, up 16%, or MSEK 19 compared with the first quarter 2018 · EBITDA increased by MSEK 11, up 64% compared with the first quarter 2018 · Early repayment of a bank loan totalling MSEK 60 reflects the strength of Probi’s balance sheet and cash flow · Ongoing launches of Probi® Osteo, for the prevention of bone loss in postmenopausal women. Strong customer interest and several customer launches planned in 2019 Financial overview MSEK Q1 Q1 2018 Full-year 2018

Ovako publishes additional climate declarations to help customers make climate-smart purchasing decisions

Ovako, which has previously published climate declarations for its Hofors, Smedjebacken and Boxholm production flows, today publishes another climate declaration for its production facility in Imatra, as well as updated versions of previous declarations. The climate declarations enable comparison of Ovako’s carbon footprint per kilogram of finished steel product, from raw material until the finished product leaves the company’s production facilities, with the global average. The declarations, which show that Ovako’s products have an 80 percent lower carbon footprint than the global

Read original

SBB, Interim Report January – March 2019: Net income after tax for the period amounted to SEK 216m

SAMHÄLLSBYGGNADSBOLAGET I NORDEN AB (PUBL): Interim Report January – March 2019 in brief: · Rental income increased to SEK 429m (390). · The operating surplus increased to SEK 240m (233). · Cash flow from operating activities before changes of working capital was SEK 97m (40). · Profit before tax was SEK 349m (151), of which: · Income from property management is included with SEK 106m (73). The management result includes costs for early redemption of loans and other non-recurring financing costs of SEK -25m. · Unrealized changes in the value of properties

Medivir appoints new CFO

Stockholm, Sweden – Medivir AB (Nasdaq Stockholm: MVIR) today announces the appointment of Magnus Christensen as new CFO of Medivir effective as of 12 August 2019. He will also join the company’s management team. In his role, Magnus will be responsible for Investor Relations as well as leading the day-to-day operations within the areas of finance, IT, HR and premises. Magnus Christensen, whose most recent position was as CFO at O’Learys Trademark, has extensive experience of managerial positions within finance from a range of companies. “I’m delighted to welcome Magnus to Medivir,”

Tecnotree signs delivery agreement on Digital BSS Suite 5 worth USD 15 million

Tecnotree CorporationStock Exchange Release29 April 2019 at 9:00 a.m. (EEST)Tecnotree has signed an agreement with one of the largest telecom operators in the Middle East region. The value of the agreement is USD 15.8 million for 2 years. Under the agreement, Tecnotree will deploy its Digital BSS Suite 5 products to help accelerate the operator’s business growth as well as increase agility and operational efficiency of their IT systems. Tecnotree has a long-standing relationship with the customer. Earlier, Tecnotree helped them to transform to a world leading CRM & Product Catalog

Hemfosa acquires properties in Sweden, Norway and Finland

Hemfosa has made acquisitions in all three markets for a total underlying property value of approximately MSEK 575 and annual rental income of about MSEK 42. The acquisitions in Sweden and Norway complement the existing portfolio in locations where Hemfosa already owns properties and offer potential for development. Hemfosa is also entering the preschool segment in Finland with the acquisition of four preschools in Oulu.Acquisitions in Sweden  In Motala, Hemfosa acquired four properties totaling about 12,800 square meters. These properties are situated in central Motala and house schools,

Share buy-backs in Telia Company during week 17 2019

During the period April 23, 2019, until April 26, 2019, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2,488,171 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 16, 2019. The share buy-back programme, which runs between April 16, 2019, and February 28, 2020, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

Aker ASA: Ex-dividend NOK 22.50 today

Reference is made to the resolution by the General Meeting in Aker ASA on 26 April 2019 to distribute a dividend of NOK 22.50 per share. Aker ASA shares will trade exclusive of dividend of NOK 22.50 per share as of today, 29 April 2019.ENDS For further information, please contact: Investors:Per Kristian Reppe, Investment Manager & Head of Investor RelationsPhone:  +47 24 13 00 67Mobile: +47 900 33 203 Media:Atle Kigen, Head of Corporate CommunicationsPhone:  +47 24 13 00 08Mobile: +47 907 84 878 This information is subject to the disclosure requirements pursuant to

VTT involved in the new Nordic venture capital fund investing in science

Voima Ventures is the first Nordic venture capital fund investing purely in science and deep technology. VTT is one of its cornerstone investors.  The Founder and Managing Partner of Voima Ventures is start-up investor Inka Mero, and VTT is accompanied by the European Investment Fund (EIF) and private individuals as cornerstone investors. The founding team includes Mikko Kumpulainen who has previously worked at VTT’s subsidiary company VTT Ventures, Vaaka Partners and BCG.  ‘The multidisciplinary expertise and innovativeness of VTT’s researchers form an excellent basis for new growth

The summer’s new products from Fazer Bakery: Treat yourself to street food

Fazer Bakery’s new products for this summer are full of the flavours of the upcoming holiday season. The main course will be Fazer Street Food, served in the form of a hamburger or hot dog bun, wrap or flatbread. For dessert, you have a mouthwatering choice of sweet delicacies – meringues or Fazer’s small chocolate cake made with dark chocolate that simply melts in your mouth. Make summer coffee breaks perfect with the smooth Fazer Mansikkapaikka cake roll and the Pullava Mansikkatäytepitko sweet bun loaf. Novelties will be available in grocery shops starting from 2 May.Fazer Street Food

Helbio receives an order to deliver a 5kW CHP system to the Pontifical Catholic University of Rio de Janeiro

Metacon subsidiary Helbio S.A has received another order from the Pontifical Catholic University of Rio de Janeiro in Brazil. The order comprise a 5kW CHP system based on reformate hydrogen production via steam reforming of natural gas and low temperature PEM fuel cell for outdoor operation. The order value do not exceed €50,000. “We share a valuable partnership with Pontifical Catholic University of Rio de Janeiro, and this additional order underpins our strong focus on customer satisfaction as well as functionality of our products and solutions” said Alexis Tzamouranis, Commercial

Graphene sponge helps lithium sulphur batteries reach new potential

To meet the demands of an electric future, new battery technologies will be essential. One option is lithium sulphur batteries, which offer a theoretical energy density roughly five times that of lithium ion batteries. Researchers at Chalmers University of Technology, Sweden, recently unveiled a promising breakthrough for this type of battery, using a catholyte with the help of a graphene sponge. The researchers’ novel idea is a porous, sponge-like aerogel, made of reduced graphene oxide, that acts as a free-standing electrode in the battery cell and allows for better and higher

NENT Group to show W Series motor racing

· NENT Group acquires exclusive Nordic rights to world’s first all women motor racing championship · W Series is the latest addition to NENT Group’s unrivalled motorsports portfolio, which includes Formula 1 and IndyCar · NENT Group shows more than 50,000 hours of the world’s best live sporting action every year Nordic Entertainment Group (NENT Group) has secured the exclusive Nordic media rights to W Series, the world’s first all women motor racing championship. Every race from the 2019 W Series season will be shown live on NENT Group’s Viaplay streaming service and Viasat pay-TV

Swedbank’s Nomination Committee will propose Göran Persson as new Chairman of the Board of Directors of Swedbank AB (publ).

Göran Persson has held a number of positions in the Swedish society. During 1994 to 1996, he held the position as Minister of Finance and following that, Prime Minister until 2006. He has been Chairman of the Board of Directors of Sveaskog, and he is currently Chairman of LKAB. Göran Persson has been member of the Board in one of the Swedish Savings Banks and is now a member of the Board of Ålandsbanken.Lennart Haglund, the Chairman of the Nomination Committee, comments: “Swedbank’s Nomination Committee has been working intensely and constructively. I called for our first meeting already

Radiotherapiegroep in the Netherlands to acquire Elekta Unity and Versa HD cancer treatment systems

STOCKHOLM, April 27, 2019 – Elekta (EKTA-B.ST) announced today that Radiotherapiegroep Arnhem/Deventer in the Netherlands has ordered an Elekta Unity MR-linac as well as five Versa HD™ linear accelerators. Elekta Unity combines two technologies – a state-of-the-art 1.5T MRI scanner and a best-in-class 7MV linear accelerator. It is transforming cancer care with the potential to preserve more healthy tissue than ever before, enabling the use of radiation therapy in hard-to-treat cancers, and going beyond anatomy with biological MRI to assess tumor responses early in treatment. Karin

There are no items matching the current filter
There are no more items matching the current filter
Back to top